Retirement Systems of Alabama Lowers Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Retirement Systems of Alabama lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 175,602 shares of the medical equipment provider's stock after selling 1,605 shares during the period. Retirement Systems of Alabama's holdings in Intuitive Surgical were worth $86,970,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of ISRG. Brighton Jones LLC grew its position in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $6,509,000. Bank of Stockton boosted its holdings in shares of Intuitive Surgical by 13.5% in the 4th quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider's stock valued at $606,000 after acquiring an additional 138 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its holdings in shares of Intuitive Surgical by 0.5% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after acquiring an additional 883 shares during the last quarter. Finally, D.A. Davidson & CO. boosted its holdings in shares of Intuitive Surgical by 0.9% in the 4th quarter. D.A. Davidson & CO. now owns 13,198 shares of the medical equipment provider's stock valued at $6,889,000 after acquiring an additional 115 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president now owns 907 shares of the company's stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock valued at $2,611,577 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Barclays dropped their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Royal Bank Of Canada decreased their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Piper Sandler decreased their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

Intuitive Surgical Stock Up 1.1%

Shares of Intuitive Surgical stock traded up $5.73 during trading hours on Monday, reaching $515.09. 1,217,351 shares of the company's stock were exchanged, compared to its average volume of 1,675,816. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The company has a market capitalization of $184.62 billion, a P/E ratio of 75.53, a price-to-earnings-growth ratio of 5.40 and a beta of 1.67. The business has a fifty day moving average of $528.53 and a two-hundred day moving average of $537.06.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.